文献速递前列腺增生与排尿功能障碍

钬激光前列腺剜除术后同日拔管失败的相关因素

Predictors of Failed Same-Day Catheter Removal After Holmium Laser Enucleation of the Prostate.
PubMed 文献 · Urology · 2022-08-10

回顾性分析190例接受钬激光前列腺剜除术(HoLEP)的患者,90%(171/190)同日排尿试验成功。术前抗凝治疗(无论是否继续)与同日拔管失败相关,继续抗凝者失败率最高(2.3% vs 15.8%,P=0.023)。

要点

  • 190例HoLEP患者中90%(171/190)同日拔管成功。
  • 术前抗凝治疗与同日拔管失败相关(4.7% vs 21.1%,P=0.021)。
  • 继续抗凝至手术者失败率最高(2.3% vs 15.8%,P=0.023)。

核心结论

  • 同日排尿试验成功的患者占90%(171/190),术前抗凝史(无论继续或暂停)增加同日拔管失败风险。

研究设计与样本

  • 单中心回顾性研究,纳入2021年7月至2022年1月接受HoLEP的190例患者。

主要发现

  • 同日拔管成功组与失败组在年龄、合并症、术前尿潴留、麻醉因素、手术时间、切除体积、剜除时间及粉碎时间上均无差异(均P>0.05)。
  • 术前抗血小板治疗与同日拔管失败无关(P=0.78),而术前抗凝治疗与失败相关(4.7% vs 21.1%,P=0.021)。
  • 继续抗凝至手术者同日拔管失败率最高(2.3%(4/171)vs 15.8%(3/19),P=0.023)。
  • 同日拔管成功者中4.1%(7/171)出院后需再次导尿,3个月时无患者需导尿。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine factors associated with failure of same-day trial of void (SDTOV) following holmium laser enucleation of the prostate (HoLEP). BACKGROUND: HoLEP is increasingly utilized for patients with benign prostatic hyperplasia. Advancements in technology have improved operative efficiency and hemostasis making same-day, catheter-free discharge possible. METHODS: We conducted a retrospective review on 190 patients undergoing HoLEP from July, 2021 to January, 2022 by a single center. We assessed pre- and intra-operative variables associated with our primary outcome: failure of same-day catheter removal. Post-operative complications and outcomes at a ≤7 days and 3-month follow up were examined. Continuous and categorical variables were analyzed using unpaired t-tests (Mann Whitney) and chi-square, respectively. Univariate and multivariable logistic regression models were fitted to examine the associations of failed SDTOV. RESULTS: Of 190 candidates for a SDTOV, 90% (171/190) were successful. We found no difference between SDTOV success and failures with regards to age, comorbidities, presence of pre-operative urinary retention, anesthesia factors, operative time, volume resected, enucleation time, and morcellation time (all P>0.05). Pre-operatively, 26.3% (50/190) were on antiplatelet and 6.3% (12/190) were on anticoagulation. While pre-operative antiplatelet therapy was not associated with SDTOV failure (P=0.78), pre-operative anticoagulation use was (4.7% vs. 21.1%, P=0.021). Patients who continued anticoagulation through surgery had the highest rate of SDTOV failure (2.3% (4/171) vs. 15.8% (3/19), P=0.023). For those with successful SDTOV, 4.1% (7/171) required catheterization following discharge. At 3 months, no patient required catheterization. CONCLUSION: On the day of surgery, patients eligible for SDTOV successfully voided 90% of the time. History of preop anticoagulation, whether continued or held, increased SDTOV failure.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Cooley LF, Assmus M, Ganesh M, et al. Predictors of Failed Same-Day Catheter Removal After Holmium Laser Enucleation of the Prostate. Urology. 2022. PMID: 35963396. doi:10.1016/j.urology.2022.07.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。